This inventor holds 1 USPTO granted patent. Top assignee: Centre Europeen De Bioprospective-Ceb. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Abdallah Deyine: Innovator in Aromatic Tetracyclic Compounds
Introduction
Abdallah Deyine is a notable inventor based in Rouen, France. He has made significant contributions to the field of chemistry, particularly in the development of aromatic tetracyclic compounds of the retinoid type. His work has implications for pharmaceutical applications, showcasing the intersection of innovation and healthcare.
Latest Patents
Deyine holds a patent for "Aromatic tetracyclic compounds of the retinoid type method for preparing and use." This invention concerns aromatic tetracyclic compounds characterized by a general formula (I). The patent also details the method for preparing these compounds and the pharmaceutical compositions that incorporate at least one of the compounds.
Career Highlights
Abdallah Deyine is associated with the Centre Européen de Bioprospective (CEB), where he has been instrumental in advancing research in bioprospecting and pharmaceutical development. His expertise in the synthesis of complex chemical compounds has positioned him as a valuable asset in his field.
Collaborations
Deyine has collaborated with notable colleagues, including Bertrand Leblond and Alain-René Schoofs. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Abdallah Deyine's contributions to the field of aromatic tetracyclic compounds exemplify the importance of innovation in pharmaceutical science. His work not only advances chemical research but also holds promise for future medical applications.